Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Vericel Corp
VCEL
$2.35B
| $8.91M | ﹤0.01% |
353,984
-3,852
| -1% | -$114K |
|
1902
Celldex Therapeutics
CLDX
$2.99B
| $8.91M | ﹤0.01% |
330,559
-6,249
| -2% | -$181K |
|
1903
Shift4
FOUR
$4.2B
| $8.9M | ﹤0.01% |
269,281
+4,005
| +2% | +$189K |
|
1904
SkinHealth Systems
SKIN
$88.8M
| $8.88M | ﹤0.01% |
690,567
+12,825
| +2% | +$172K |
|
1905
Hanmi Financial
HAFC
$945M
| $8.87M | ﹤0.01% |
395,427
-2,847
| -0.7% | -$66K |
|
1906
Adaptive Biotechnologies
ADPT
$3.59B
| $8.85M | ﹤0.01% |
1,093,618
+233,850
| +27% | +$2.06M |
|
1907
Nomad Foods
NOMD
$1.66B
| $8.82M | ﹤0.01% |
441,446
+133,135
| +43% | +$2.69M |
|
1908
Heartland Express
HTLD
$948M
| $8.81M | ﹤0.01% |
633,299
+37,986
| +6% | +$525K |
|
1909
Peloton Interactive
PTON
$2.77B
| $8.77M | ﹤0.01% |
955,183
+17,839
| +2% | +$286K |
|
1910
Agilysys
AGYS
$2.97B
| $8.74M | ﹤0.01% |
184,999
-7,191
| -4% | -$280K |
|
1911
Arcus Biosciences
RCUS
$3.55B
| $8.7M | ﹤0.01% |
343,281
+12,630
| +4% | +$309K |
|
1912
Agios Pharmaceuticals
AGIO
$1.79B
| $8.68M | ﹤0.01% |
391,586
-3,662
| -0.9% | -$82.7K |
|
1913
CareDx
CDNA
$2.26B
| $8.68M | ﹤0.01% |
404,172
-4,851
| -1% | -$135K |
|
1914
Virgin Galactic
SPCE
$328M
| $8.68M | ﹤0.01% |
72,068
+22,965
| +47% | +$3.33M |
|
|
AGNT
1915
AGNT Inc
AGNT
$666M
| $8.66M | ﹤0.01% |
736,206
+7,242
| +1% | +$105K |
|
1916
Revolution Medicines
RVMD
$39.9B
| $8.66M | ﹤0.01% |
444,403
+191
| +0% | +$3.72K |
|
1917
AerCap
AER
$23.7B
| $8.63M | ﹤0.01% |
210,706
-17,834
| -8% | -$826K |
|
|
WOW
1918
DELISTED
WideOpenWest
WOW
| $8.62M | ﹤0.01% |
473,286
+48,364
| +11% | +$972K |
|
1919
Kura Oncology
KURA
$800M
| $8.61M | ﹤0.01% |
469,589
-8,328
| -2% | -$120K |
|
1920
Opko Health
OPK
$985M
| $8.58M | ﹤0.01% |
3,392,673
-478,230
| -12% | -$1.39M |
|
1921
Brown-Forman Class A
BF.A
$13.4B
| $8.57M | ﹤0.01% |
126,628
-397
| -0.3% | -$25.2K |
|
|
HIBB
1922
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $8.55M | ﹤0.01% |
195,513
-1,346
| -0.7% | -$62.1K |
|
|
PING
1923
DELISTED
Ping Identity Holding Corp.
PING
| $8.54M | ﹤0.01% |
470,786
+31,808
| +7% | +$707K |
|
1924
Columbus McKinnon
CMCO
$553M
| $8.46M | ﹤0.01% |
298,054
+17,468
| +6% | +$601K |
|
1925
Vicor
VICR
$9.56B
| $8.43M | ﹤0.01% |
153,925
-1,254
| -0.8% | -$77.8K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.